Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer’s diseases therapy
-
Published:2024-10
Issue:
Volume:151
Page:107651
-
ISSN:0045-2068
-
Container-title:Bioorganic Chemistry
-
language:en
-
Short-container-title:Bioorganic Chemistry
Author:
Soltan Osama M.,
Abdelrahman Kamal S.,
Bass Amr K.A.,
Takizawa Kazuki,
Narumi Atsushi,
Konno HiroyukiORCID
Reference162 articles.
1. Discovery of the first-in-class GSK-3β/HDAC dual inhibitor as disease-modifying agent to combat Alzheimer’s disease;De Simone;ACS Med. Chem. Lett.,2019
2. The neuropathological diagnosis of Alzheimer’s disease;DeTure;Mol. Neurodegener.,2019
3. Design, molecular Docking, synthesis and evaluation of xanthoxylin hybrids as dual inhibitors of IL-6 and acetylcholinesterase for Alzheimer's disease;Kaur;Bioorg. Chem.,2022
4. Design, synthesis, and evaluation of some novel biphenyl imidazole derivatives for the treatment of Alzheimer's disease;Ramrao;J. Mol. Struc.,2021
5. Design, synthesis, and biological evaluation of novel N-Benzyl piperidine derivatives as potent HDAC/AChE inhibitors for Alzheimer’s disease;Qin;Bioorg. Med. Chem.,2023